论文信息 - Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year - 字舞流文

Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year

John E. Murphy | J. Rasko | D. Rybin | X. Anguela | K. High | J. Teitel | C. McGuinn | J. Ducore | L. George | B. Samelson-Jones | Alexa R. Runowski | J. Rupon | A. Giermasz | S. Sullivan | Fraser Wright